Published: Guidance, quality standards and advice
Showing 1 to 1 of 1
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Loncastuximab tesirine for treating relapsed or refractory diffuse large B-cell lymphoma and high-grade B-cell lymphoma after 2 or more systemic treatments | TA947 |